CorMedix CRMD
NASDAQ CRMD
$7.72 +0.15 (+1.98%)
As of: Oct 21, 2026 · 11:11 AM EDT

CorMedix (CRMD) Capital Leases (2025)

Updated

CorMedix's Capital Leases was $586,000 in Q4 2025, up 5.1% from the prior quarter.

Analysis

CorMedix (CRMD) Capital Leases (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,129.91 Bn 1,098.50 Bn 19.71 Bn
2 Johnson & Johnson 613.69 Bn 532.22 Bn 17.26 Bn
3 AbbVie 503.05 Bn 476.16 Bn 12.70 Bn
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn
6 Astrazeneca 261.30 Bn 234.99 Bn 12.86 Bn
7 Amgen 235.86 Bn 191.25 Bn 7.24 Bn
8 Gilead Sciences 190.51 Bn 164.71 Bn 6.22 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn
10 CorMedix 605.59 Mn -46.93 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 586,000.00
Sep 30, 2025 557,413.00
API Access

CorMedix Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=CRMD&period=max&api_key=YOUR_API_KEY